# An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)

> **NCT00076973** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1125 (actual)

## Conditions studied

- Bronchiolitis

## Interventions

- **DRUG:** montelukast sodium
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00076973
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-06
- **Final completion:** 2006-10
- **Target enrollment:** 1125 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076973, "An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00076973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*